The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
The Camarico Investment Group Ltd. is an innovative investment issuer engaged in the integrated development, acquisition and partnership of intellectual property, assets and portfolio interests.
Canada House Wellness Group Inc. is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; Canada House Clinics Inc., clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from common to complex medical conditions; IsoCanMed Inc., a Licensed Producer in Louiseville, Quebec, that produces high quality medical grade cannabis; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis.
Canada House Wellness Group’s goal is to become the leading cultivator of premium craft cannabis and provider of cannabinoid therapy, targeting the medical cannabis markets globally. Please visit www.canadahouse.ca.
CanaFarma Hemp is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.
Investor Note: In addition to the 213,211,781 common shares that are listed and trading, there are 5,700,000 reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting Shares that are issued and outstanding but not listed. The total number of issued shares assuming all are converted into the listed class would be 218,911,781.
The issuer is a science and technology health and wellness company that encompasses plant based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals.
CannAmerica Brands Corp. is a U.S. marine veteran founded and operated portfolio of cannabis brands with licensing agreements in the states of Colorado, Nevada and Maryland. CannAmerica aims to maximize the value of its brands by employing strong brand management teams, marketing and licensing the brands through various distribution channels, including dispensaries, wholesalers and distributors, in the United States and internationally.
Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.
Cansortium Inc. is a medical cannabis company operating in highly populous medical cannabis markets with a mission to deliver the highest standards of cannabis care from nursery to lab to shelf. Headquartered in Miami, FL and operating under the Fluent™ Cannabis Care brand, the Company operates in Florida, Texas and Pennsylvania, and has partnered with a license-holder in Michigan. For more information please visit www.getfluent.com.
Investor Note: In addition to the 113,803,920 Common Shares that are listed and trading, there are 7,411,183 Proportionate Voting Shares, convertible into Common Shares at a ratio of 1:10, that are issued and outstanding but not listed. The total number of issued shares, assuming all are converted into the listed class, would be 187,915,750.
CBD Global Sciences, Inc. (“CBD Global”), is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals. CBD Global’s hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online. Through its wholly owned subsidiary, Strasburg Pharms, CBD Global grows and operates irrigated land in Colorado, that grows hemp with only all-natural Colorado water, soil, sun and nutrients and never sprayed with pesticides or chemicals. Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD. The extraction/processing facility, operated by CBD Global, is located approximately 40 minutes from the farm.
The business of the Issuer is the development of non-alcoholic beverages and the generation of retail sales.
Advertisement
Publicité
Advertisement
Publicité
